Moeez Ghani Rathore

1) Tumor cell-secreted Pentraxin 3 contributes to melanoma aggressiveness. Moeez G. Rathore, M. Tichet, C. Girard, E. Garcia, V. Prod’Homme, M. Deckert, S. Tartare-Deckert Manuscript Submitted to Oncogene.
2) The Ashitaba (Angelica keiskei) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K. Tianshun Zhang, Qiushi Wang, Mangaladoss Fredimoses, Ge Gao, Keke Wang, Hanyong Chen, Ting Wang, Naomi Oi, Tatyana A. Zykova, Kanamata Reddy, Ke Yao, Weiya Ma, Xiaoyu Chang, Mee-Hyun Lee, Moeez Ghani Rathore, Ann M. Bode, Hitoshi Ashida, Scott M. Lippman and Zigang Dong. Canncer Preventive Research 2018.
3) Human leukemic cells performing OXPHOS generate and antioxidant response independently of ROS generation. Abrar Ul Haq Khan, Moeez G. Rathore, Nerea Allende-Vega, Dang-Nghiem Vo, Sana Belkhala, Guillaume Cartron, Charles-Henri Lecellier and Martin Villalba. ebioMedicine.2015
4) IFNα signaling through PKC-θ is essential for antitumor NK cell function. Comet NR, Aguiló JI, Rathoré MG, Catalán E, Garaude J, Uzé G, Naval J, Pardo J, Villalba M, Anel A. Oncoimmunology. 2014 Nov 14;3(8):e948705.
5) All-trans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity. Sanchez-Martínez D, Krzywinska E, Rathore MG, Saumet A, Cornillon A, Lopez-Royuela N, Martínez-Lostao L, Ramirez-Labrada A, Lu ZY, Rossi JF, Fernández-Orth D, Escorza S, Anel A, Lecellier CH, Pardo J, Villalba M. Int J Biochem Cell Biol. 2014 Apr;49:42-52.
6) Chemical metabolic inhibitors for the treatment of blood-borne cancers. Villalba M, Lopez-Royuela N, Krzywinska E, Rathore MG, Hipskind RA, Haouas H, Allende-Vega N. Anticancer Agents Med Chem. 2014 Feb;14(2):223-32.
7) Extracellular-signal-regulated kinase 5 modulates the antioxidant response by transcriptionally controlling Sirtuin 1 expression in leukemic cells. Rathore MG, Lopez-Royuela N, , Allende-Vega N, Annicotte JS, Fajas L, Ramachandran B, Gulick T, Villalba M. Int J Biochem Cell Biol. 2014 Aug;53:253-61.
8) From tumor cell metabolism to tumor immune escape. Villalba M, Rathore MG, Lopez-Royuela N, Krzywinska E, Garaude J, Allende-Vega N. Int J Biochem Cell Biol. 2013 Jan;45(1):106-13.
9) The NF-κB member p65 controls glutamine metabolism through miR-23a. Rathore MG, Saumet A, Rossi JF, de Bettignies C, Tempé D, Lecellier CH, Villalba M. Int J Biochem Cell Biol. 2012 Sep; 44(9):1448-56.
10) Protein Kinase C-θ (PKC-θ) in Natural Killer Cell Function and Anti-Tumor Immunity.Anel A, Aguiló JI, Catalán E, Garaude J, Rathore MG, Pardo J, Villalba M. Front Immunol. 2012 Jul 5;3:187.
11) Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway.
Charni S, de Bettignies G, Rathore MG, Aguiló JI, van den Elsen PJ, Haouzi D, Hipskind RA, Enriquez JA, Sanchez-Beato M, Pardo J, Anel A, Villalba M. J Immunol. 2010 Sep 15;185(6):3498-503.